Expanding antiviral therapy indications for HBeAg-negative chronic hepatitis B patients with normal ALT and positive HBV DNA

With the improved efficacy and accessibility of antiviral agents as well as the concerns about disease progression, there is a hot discussion on whether HBeAg-negative chronic hepatitis B (CHB) patients with normal alanine aminotransferase (ALT) and positive HBV DNA should be treated. According to t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Jing, Wang, Fada, Li, Lanqing, Chen, Enqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Minireview
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745772/
https://www.ncbi.nlm.nih.gov/pubmed/36519139
http://dx.doi.org/10.1093/pcmedi/pbac030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745772/
https://www.ncbi.nlm.nih.gov/pubmed/36519139
http://dx.doi.org/10.1093/pcmedi/pbac030

Ejemplares similares